CS logo
small CS logo
Queen Elizabeth II Hospital

Welwyn Garden City, United Kingdom
Hospital in Welwyn Garden City, England
Howlands, Welwyn Garden City AL7 4HQ

About Queen Elizabeth II Hospital


The New QEII Hospital is located in Welwyn Garden City and managed by East and North Hertfordshire NHS Trust.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
3
Bayer
1
Cardiff and Vale University Health Board
1
Institute of Cancer Research, United Kingdom
1
Pfizer
1
Total Rows: 5

Clinical Trials at Queen Elizabeth II Hospital


During the past decade, Queen Elizabeth II Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years110000000011110000111111Started TrialsCompleted Trails20152016201720182019202000.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Colitis Once Daily Asacol Study
2006-10-01
2010-09-01
Completed
213
A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung
2011-01-13
2016-11-30
Completed
343
GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)
2012-08-22
2019-12-13
Completed
10,471
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
Trial of Perioperative Endocrine Therapy - Individualising Care
2008-09-01
2034-04-01
Active, not recruiting
4,486
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)
2015-06-30
2017-10-23
Completed
730
Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications.
2020-01-30
2021-10-08
Completed
755

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Queen Elizabeth II Hospital" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Bayer" with 1 trials sponsored, "Cardiff and Vale University Health Board" with 1 trials sponsored, "Institute of Cancer Research, United Kingdom" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Elizabeth II Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Procter and Gamble" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 3Boehringer Ingelheim: 3Bayer: 1Bayer: 1Cardiff and ValeUniversity HealthBoard: 1Cardiff and ValeUniversity HealthBoard: 1Institute of CancerResearch, UnitedKingdom: 1Institute of CancerResearch, UnitedKingdom: 1Pfizer: 1Pfizer: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 2Eli Lilly and Company: 2Procter and Gamble: 1Procter and Gamble: 1

Clinical Trials Conditions at Queen Elizabeth II Hospital


According to Clinical.Site data, the most researched conditions in "Queen Elizabeth II Hospital" are "Atrial Fibrillation" (1 trials), "Atrial Fibrillation (AF)" (1 trials), "Breast Cancer" (1 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Queen Elizabeth II Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Queen Elizabeth II Hospital


Most popular intervention types in "Queen Elizabeth II Hospital" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Aromatase Inhibitors" (1 trials) and "BAY2433334" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Queen Elizabeth II Hospital


The vast majority of trials in "Queen Elizabeth II Hospital" are 6 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Queen Elizabeth II Hospital


Currently, there are NaN active trials in "Queen Elizabeth II Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Queen Elizabeth II Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Queen Elizabeth II Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4Phase 2: 1Phase 2: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 6Completed: 6Active, not recruiting: 1Active, not recruiting: 1